Regarding ovarian cancer, a study by Webb et al. on high-grade serous ovarian cancer showed that PD-L1 expressed by tumor-associated macrophages (TAM) was significantly associated with favorable disease-specific survival after anti-PD-1 antibody therapy [9]. The gene discussed is CD274; the disease is neoplasm.